Latest Commercialisation News

Proteomics International has validated its PromarkerEndo blood test as a highly accurate, non-invasive diagnostic tool for endometriosis, with commercial launch planned in Australia for Q3 2025. The test promises to reduce the average seven-year diagnostic delay by providing a simple risk score applicable across all disease stages.

GreenHy2 Limited has broadened its renewable energy storage portfolio by integrating graphene-based hybrid supercapacitor batteries, reporting robust FY24 growth and advancing key customer trials.

EBR Systems has announced a fully underwritten A$55.9 million capital raise alongside a Security Purchase Plan to fund the commercial rollout of its FDA-approved WiSE CRT System, targeting a US$3.6 billion market opportunity in cardiac resynchronization therapy.

EBR Systems has raised A$55.9 million through a fully underwritten placement to fund the commercial rollout of its FDA-approved wireless cardiac pacing system, with plans for a limited market release in H2 2025 and expanded distribution in 2026.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

Nufarm reported a mixed 1H25 with a strong rebound in crop protection profits contrasting a sharp decline in seed technologies earnings, prompting a strategic review of the latter business.

Estrella Resources has entered a landmark Master Agreement with Indonesian firm PT Raka Energi Mandiri, granting exclusive rights to market and purchase limestone from Timor-Leste, targeting sales of up to 500 million tonnes over five years.

Echo IQ’s application for a key US procedural code was rejected but the company plans a swift resubmission, maintaining confidence in its US commercial rollout.

Blue Star Helium has commenced drilling the State 9 well at its Galactica helium project in Colorado, marking a significant step in its helium development program. The well is progressing toward the Lyons Formation reservoir with plans for flow testing and production tie-in.

EMVision Medical Devices has enhanced its AI-powered stroke diagnostic algorithm, achieving a notable 95% sensitivity and 80% specificity in recent tests. This progress sets the stage for upcoming pivotal trials and regulatory milestones.

High-Tech Metals has signed a joint venture with SSH Mining to drill, test, and sell historic low-grade gold stockpiles at Mt Fisher, aiming for early cash flow and project advancement.

LTR Pharma has appointed Associate Professor Darren Katz, a leading urologist and erectile dysfunction expert, to its Scientific Advisory Board, aiming to fast-track the development and commercialization of its innovative nasal spray treatments SPONTAN and ROXUS.